Stay updated on Uproleselan High Dose Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Uproleselan High Dose Combo in AML Clinical Trial page.

Latest updates to the Uproleselan High Dose Combo in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe history now shows that recruitment has stopped for the study and the version history has advanced to Revision: v3.6.0, replacing Revision: v3.5.5.SummaryDifference0.2%

- Check21 days agoChange DetectedArms and Interventions, Study Description, and Study Status were added to the history to reflect updated core study content. A new revision (v3.5.5) dated 2026-06-02 records the updated study details.SummaryDifference0.4%

- Check42 days agoChange DetectedAn entry 'Revision: v3.5.4' was added to the study record history. The previous 'Revision: v3.5.3' entry was removed, updating the page's versioning information within the history.SummaryDifference0.1%

- Check49 days agoChange DetectedThe record history now adds major study-data sections such as Results Posted, More Information, Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, Document Section, Outcome Measures, Arms and Interventions, Study Description, and Study Status. A prior entry 'Results Submitted' was removed, indicating a shift toward posted results in the record.SummaryDifference0.8%

- Check63 days agoChange DetectedThe page now displays a different ClinicalTrials.gov interface revision/version number (updating from v3.5.2 to v3.5.3), indicating a site/software update rather than changes to the trial history content.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision updated to v3.5.2. The previous revision v3.5.0 was removed.SummaryDifference0.1%

Stay in the know with updates to Uproleselan High Dose Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan High Dose Combo in AML Clinical Trial page.